These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 9209674)
1. Interferon-alpha-2b in the management of patients with relapsed and/or refractory Hodgkin's disease. Maloisel F; Voillat L; Chenard MP; Boehn A; Lioure B; Oberling F Ann Oncol; 1997 Apr; 8(4):405-6. PubMed ID: 9209674 [No Abstract] [Full Text] [Related]
2. Alpha interferon in patients with progressive and/or recurrent Hodgkin's disease. Koziner B Eur J Cancer; 1991; 27 Suppl 4():S79-80. PubMed ID: 1799488 [No Abstract] [Full Text] [Related]
3. Interferon therapy of relapsed and refractory Hodgkin's disease: Cancer and Leukemia Group B Study 8652. Rybak ME; McCarroll K; Bernard S; Lester E; Barcos M; Ozer H; Bloomfield CD; Gottlieb AJ J Biol Response Mod; 1990 Feb; 9(1):1-4. PubMed ID: 2319256 [TBL] [Abstract][Full Text] [Related]
5. Maintenance therapy with interferon alfa 2b in Hodgkin's disease. Avilés A; Díaz-Maqueo JC; Talavera A; Nambo MJ; García EL Leuk Lymphoma; 1998 Aug; 30(5-6):651-6. PubMed ID: 9711927 [TBL] [Abstract][Full Text] [Related]
6. Nivolumab-induced cytokine-release syndrome in relapsed/refractory Hodgkin's lymphoma: a case report and literature review. Zhao L; Yang Y; Li W; Li T; Gao Q Immunotherapy; 2018 Aug; 10(11):913-917. PubMed ID: 30149764 [TBL] [Abstract][Full Text] [Related]
7. Modulation of chemosensitivity by alpha interferon in multiple myeloma and non-Hodgkin's lymphoma. Iaffaioli RV; Facchini G; Tortoriello A; Scala S; Pacelli R; La Mura G; Pagliarulo C; Palmieri G; Caponigro F J Exp Ther Oncol; 1996 Jul; 1(4):226-30. PubMed ID: 9414408 [TBL] [Abstract][Full Text] [Related]
8. Pregnancy during alpha-interferon therapy in patients with advanced Hodgkin's disease. Ferrari VD; Jirillo A; Lonardi F; Pavanato G; Bonciarelli G Eur J Cancer; 1995 Nov; 31A(12):2121-2. PubMed ID: 8562182 [No Abstract] [Full Text] [Related]
9. A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma. Hosein PJ; Craig MD; Tallman MS; Boccia RV; Hamilton BL; Lewis JJ; Lossos IS Am J Hematol; 2012 Jan; 87(1):111-4. PubMed ID: 22081459 [No Abstract] [Full Text] [Related]
10. Phase I/II study of cyclophosphamide, carboplatin, and etoposide and autologous hematopoietic stem-cell transplantation with posttransplant interferon alfa-2b for patients with lymphoma and Hodgkin's disease. Schenkein DP; Dixon P; Desforges JF; Berkman E; Erban JK; Ascensao JL; Miller KB J Clin Oncol; 1994 Nov; 12(11):2423-31. PubMed ID: 7964959 [TBL] [Abstract][Full Text] [Related]
11. Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study. Locatelli F; Mauz-Koerholz C; Neville K; Llort A; Beishuizen A; Daw S; Pillon M; Aladjidi N; Klingebiel T; Landman-Parker J; Medina-Sanson A; August K; Sachs J; Hoffman K; Kinley J; Song S; Song G; Zhang S; Suri A; Gore L Lancet Haematol; 2018 Oct; 5(10):e450-e461. PubMed ID: 30290902 [TBL] [Abstract][Full Text] [Related]
12. Caution with regard to the efficacy of interferon alfa-2b in the treatment of giant hemangiomas. Léauté-Labrèze C; Taïeb A Arch Dermatol; 1998 Oct; 134(10):1297-8. PubMed ID: 9801696 [No Abstract] [Full Text] [Related]
13. The role of interferon alpha 2b as an adjunctive treatment in the management of aggressive basal cell carcinoma of the eyelids. Fenton S; Kennedy S; Moriarty P Acta Ophthalmol Scand; 2002 Dec; 80(6):674-5. PubMed ID: 12485296 [No Abstract] [Full Text] [Related]
14. Current and future uses of recombinant interferon alpha in the treatment of low-grade non-Hodgkin's lymphoma. Steis RG; Foon KA; Longo DL Cancer; 1987 Feb; 59(3 Suppl):658-63. PubMed ID: 10822466 [TBL] [Abstract][Full Text] [Related]
15. Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial. Moskowitz CH; Nademanee A; Masszi T; Agura E; Holowiecki J; Abidi MH; Chen AI; Stiff P; Gianni AM; Carella A; Osmanov D; Bachanova V; Sweetenham J; Sureda A; Huebner D; Sievers EL; Chi A; Larsen EK; Hunder NN; Walewski J; Lancet; 2015 May; 385(9980):1853-62. PubMed ID: 25796459 [TBL] [Abstract][Full Text] [Related]
20. Interferon alpha-2B and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial. Barbaro G; Di Lorenzo G; Belloni G; Ferrari L; Paiano A; Del Poggio P; Bacca D; Fruttaldo L; Mongiò F; Francavilla R; Scotto G; Grisorio B; Calleri G; Annese M; Barelli A; Rocchetto P; Rizzo G; Gualandi G; Poltronieri I; Barbarini G Am J Med; 1999 Aug; 107(2):112-8. PubMed ID: 10460040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]